Aurobindo Pharma (AUROPHARMA) Share Price Falls 2.66% Today as Market Cap Stands at Rs 92,923.53 Cr
- September 30, 2026
- Posted by: Kunal Singla
- Category: News
Aurobindo Pharma Share Price is under pressure in today’s trade, with the stock last traded at Rs 1,572.10, down 2.66% from the previous close of Rs 1,615. The company’s market capitalisation stands at Rs 92,923.53 Cr, keeping Aurobindo Pharma in the Large Cap category. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The move is relevant because the Aurobindo Pharma Share Price now sits below the previous close while the stock remains inside a broad healthcare valuation set where peer multiples and return ratios provide important context. For readers tracking Aurobindo Pharma Share Price Today, the key question is not only what changed in the stock price, but how the day’s numbers fit into Aurobindo Pharma Stock News, Aurobindo Pharma Share Price News and Aurobindo Pharma Fundamental Analysis.
Aurobindo Pharma (AUROPHARMA) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 1,572.1 |
| Previous Close | Rs 1,615 |
| Today's Move | -Rs 42.90 (-2.66%) |
| Open | Rs 1,621.4 |
| High | Rs 1,635.35 |
| Low | Rs 1,571 |
| Market Capitalisation | Rs 92,923.53 crore |
| Market Cap Category | Large Cap |
Aurobindo Pharma Share Price Today reflects a clear intraday decline. The stock opened at Rs 1,621.40, touched a high of Rs 1,635.35 and a low of Rs 1,571.00, before last trading at Rs 1,572.10. That places the Aurobindo Pharma Share Price close to the day’s low and Rs 42.90 below the previous close. The day change of -2.66% is the main price signal, while the market cap of Rs 92,923.53 Cr confirms the company’s Large Cap profile. In Aurobindo Pharma Stock Performance terms, the session has been a downside day rather than a range-building day. For investors following Aurobindo Pharma Share Price Live and Aurobindo Pharma Share Price Update, the data shows a lower trade after a stronger open. That sets up the next question around Aurobindo Pharma Fundamental Analysis and whether valuation and operating ratios give the Aurobindo Pharma Share Price enough support.
Aurobindo Pharma (AUROPHARMA) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 92,923.53 crore |
| P/E Ratio | 25.03x |
| P/B Ratio | 2.39x |
| ROE | 9.93% |
| ROCE | 12.76% |
| EPS | Rs 64.52 |
| Book Value Per Share | Rs 676.49 |
| Dividend Yield | 0.25% |
Aurobindo Pharma (AUROPHARMA) fundamental metrics show P/E 25.03x, P/B 2.39x, ROE 9.93%, ROCE 12.76%. These figures provide context only and are not a buy or sell signal.
Aurobindo Pharma has a market capitalisation of Rs 92,923.53 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 25.03x, P/B at 2.39x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 9.93% and ROCE of 12.76%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 64.52, book value per share of Rs 676.49, dividend yield of 0.25%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.73x, median ROE of 11.33%, median ROCE of 13.25%. Taken together, they outline the fundamentals rather than a view on the stock.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 25.03x |
| Benchmark Median P/E | 31.73x |
| Benchmark Average P/E | 45.98x |
| Benchmark P/E Range | 3.1x to 616.89x |
| Company P/B Ratio | 2.39x |
| Benchmark Median P/B | 2.76x |
| Benchmark Average P/B | 4.11x |
| Company ROE | 9.93% |
| Benchmark Median ROE | 11.33% |
| Benchmark Average ROE | 10.14% |
| Company ROCE | 12.76% |
| Benchmark Median ROCE | 13.25% |
| Benchmark Average ROCE | 13.05% |
| Company Market Capitalisation | Rs 92,923.53 crore |
| Benchmark Median Market Cap | Rs 771.43 crore |
| Benchmark Average Market Cap | Rs 13,467.03 crore |
Aurobindo Pharma (AUROPHARMA) operates in the Healthcare sector, within the Pharmaceuticals & Drugs industry.
Aurobindo Pharma (AUROPHARMA) has a P/E ratio of 25.03x, which is below the benchmark median of 31.73x, a difference of -21.12%. On its own, the P/E gap is a valuation reference point, not a trading call.
Aurobindo Pharma (AUROPHARMA) has a ROE of 9.93%, which is below the benchmark median of 11.33%, a difference of -12.36%. Aurobindo Pharma (AUROPHARMA) has a ROCE of 12.76%, which is below the benchmark median of 13.25%, a difference of -3.7%.
Track stocks among today's decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,18,683.95 | 34.61 | 4.84 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,41,310.94 | 82.5 | 13.66 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,73,078.79 | 79.36 | 19.28 | 26.76 | 19.27 |
| Laurus Labs | LAURUSLABS | 1,11,433.99 | 101.92 | 19.76 | 18.31 | 18.2 |
| Zydus Lifesciences | ZYDUSLIFE | 1,11,022.18 | 24.6 | 4.12 | 19.69 | 21.39 |
Aurobindo Pharma (AUROPHARMA) has a P/E ratio of 25.03x compared with the displayed peer median of 79.36x. This peer read is a relative benchmark rather than a trading signal. Its ROE of 9.93% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 12.76% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Aurobindo Pharma (AUROPHARMA) has a market capitalisation of Rs 92,923.53 crore. All 5 peers shown have a larger market capitalisation.
Why Investors Are Watching Aurobindo Pharma
- Aurobindo Pharma Share Price fell 2.66% today, so the day’s move is the first point investors will notice.
- The stock last traded at Rs 1,572.10, below the previous close of Rs 1,615, which keeps Aurobindo Pharma Share Price Today in focus.
- P/E at 25.03 is below the same-industry median of 31.73, so valuation remains part of the Aurobindo Pharma Fundamental Analysis.
- ROE of 9.93% and ROCE of 12.76% sit below the benchmark medians, which adds context to Aurobindo Pharma Stock News.
- The Large Cap market cap of Rs 92,923.53 Cr keeps Aurobindo Pharma Share Price relevant within healthcare peer comparison.
About Aurobindo Pharma
Aurobindo Pharma operates in the Pharmaceuticals & Drugs industry within the Healthcare sector. The company is part of the Large Cap universe and carries a market capitalisation of Rs 92,923.53 Cr. Its business context in Aurobindo Pharma Stock News is shaped by its position as a significant listed pharma company rather than a niche player. For readers following Aurobindo Pharma Share Price, the main company-level context is that the stock belongs to a sector where valuation and return ratios are closely watched against peers. Univest data places the company in a highly competitive healthcare set, where Aurobindo Pharma Share Price is assessed alongside larger and higher-multiple names in the same industry.
Track Aurobindo Pharma Share Price on Univest
Use Aurobindo Pharma (AUROPHARMA) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners and related market analysis.
You can track Aurobindo Pharma Share Price on Univest for live price updates, fundamental ratios, 52-week levels and market insights in one place. The platform also helps readers follow Aurobindo Pharma Stock News, Aurobindo Pharma Share Price Today and Aurobindo Pharma Share Price Update with company-level context. If you want a quick read on valuation, sector positioning and peer comparison, Univest keeps those details easy to follow.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Uniresearch Global Pvt. Ltd. (Research Analyst, SEBI Reg. No. INH000013776, a subsidiary of Univest Communication Technologies Private Limited).
Frequently Asked Questions
Why did Aurobindo Pharma Share Price fall today?
Ans. Aurobindo Pharma Share Price fell 2.66% today and last traded at Rs 1,572.10. According to Univest data, the price event is confirmed, but no company-specific catalyst is established. The previous close was Rs 1,615.
What is Aurobindo Pharma Share Price today?
Ans. Aurobindo Pharma Share Price Today stood at Rs 1,572.10. The stock moved from an opening of Rs 1,621.40 and stayed below the previous close of Rs 1,615 during the latest trade update.
How much did Aurobindo Pharma Share Price change today?
Ans. Aurobindo Pharma Share Price declined by Rs 42.90, which translates into a 2.66% fall from the previous close of Rs 1,615. The move was recorded during the ongoing trading session.
What is Aurobindo Pharma’s market capitalisation?
Ans. Aurobindo Pharma has a market capitalisation of Rs 92,923.53 Cr. That places the company in the Large Cap category and well above the same-industry median market capitalisation in the latest Univest data.
How does Aurobindo Pharma compare on valuation?
Ans. Aurobindo Pharma’s P/E ratio is 25.03 and P/B ratio is 2.39. Both sit below the same-industry median levels, which makes the Aurobindo Pharma Share Price comparatively moderate on those measures.
What do EPS and book value show for Aurobindo Pharma?
Ans. Aurobindo Pharma’s EPS is Rs 64.52 and book value is Rs 676.49. EPS shows earnings attributable to each share, while book value shows the accounting net worth behind each share.
What is Aurobindo Pharma’s dividend yield?
Ans. Aurobindo Pharma has a dividend yield of 0.25%. This is a historical and current payout indicator, so it should be read alongside price action, valuation and other fundamentals rather than in isolation.
How does Aurobindo Pharma compare with pharma peers?
Ans. In the latest Univest data, Aurobindo Pharma’s P/E is lower than Sun Pharma, Divi’s Laboratories, Torrent Pharmaceuticals and Laurus Labs, while its market capitalisation is smaller than Sun Pharma but larger than some other listed peers.
Should investors track Aurobindo Pharma Share Price on Univest?
Ans. Yes, Aurobindo Pharma Share Price can be tracked on Univest for live updates, valuation ratios, market capitalisation and peer context. That helps readers follow Aurobindo Pharma Stock Analysis without relying on scattered market updates.
